Clinical Tip on Long Acting Antipsychotic Medications by Elizabeth Alexander - Issuu
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry
Pandemic Shows Value of Long-Acting Injectables for Severe Mental Illness - U.S. Medicine
JCM | Free Full-Text | Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction
Episode 167: Long-Acting Injectables with Dr. Cummings — Psychiatry & Psychotherapy Podcast
Table 2 from Effectiveness of long-acting antipsychotics in clinical practice : 1. A retrospective, 18-month follow up and comparison between paliperidone palmitate, risperidone long-acting injection and zuclopenthixol decanoate | Semantic Scholar
Antipsychotic switching - Wikipedia
When should you consider combining 2 long-acting injectable antipsychotics? | MDedge Psychiatry
Lesson: Assessing the Current Antipsychotics Landscape
Long-acting injectable antipsychotics: what, when, and how | CNS Spectrums | Cambridge Core
Healthcare | Free Full-Text | Long-Acting Injectable Antipsychotics (LAIs) Prescribing Trends during the COVID-19 Pandemic in Romania
Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review | Semantic Scholar
Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia | Psychiatrist.com
Why are long-acting injectable antipsychotics still underused? | BJPsych Advances | Cambridge Core
Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies | Schizophrenia
Prospective observational studies with a first-generation antipsychotic... | Download Table